A clinical trial to study the effect of drug NIA/KS/2022-03 on the patients of dadru.

Pathophysiological study of rakta pradosaja vikara and experimental study and randomized controlled trial to evaluate the efficacy of NIA/KS/2022-03 on dadru - NIL

Status

Recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058494

Enrollment

Registered

2023-10-10

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B359- Dermatophytosis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Subject with classical sign and symptoms of dadru kuÅ?á¹ha i.e., kaá¹? ?Å«, r ?ga, pi ?ik ?, utsanna maá¹? ?ala since less than 1 year. Subjects with total symptom score less than 60%.

Exclusion criteria

Exclusion criteria: Known cases of any other skin illness, chronic systemic diseases, uncontrolled diabetes mellitus, malignancy. Taking any other medication for the same disease condition. Immunocompromised subjects

Design outcomes

Primary

Measure	Time frame
Change in total symptom score of the patient, i.e., change in the grading of sign & symptoms of dadru.Timepoint: 7 Weeks	—

Secondary

Measure	Time frame
Change in the score of dermatology life quality index (DLQI).Timepoint: 6 WEEKS	—

Countries

India

Contacts

Public ContactDr Gurpreet Kaur Gill

National Institute of Ayurveda, Deemed to be University, Jaipur

dr.yadavcr@gmail.com9460866101

Outcome results